Overall verdict
Neutral
6.2/10
1-year performance
+13.63%
Score breakdown
Up 13.6% over 1 year, 47% of the 52-week range.
Strongest: Profitability 8.2/10. Weakest: Growth 5.2/10.
26 analysts, target +0.1% vs the price.
Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Asia, Europe, the Middle East, and Africa. It operates through Institutional Securities, Wealth Management, and Investment Management segments. The company offers capital raising and financial advisory services, including services related to the underwriting of debt, equity securities, and other products, as well as advice on mergers and acquisitions, restructurings, and project finance.
It also provides equity and fixed income products comprising sales, financing, prime brokerage, and market-making services ; Asia wealth management ; business-related investments services ; originating corporate and commercial real estate loans, secured lending facilities, and extending securities-based and other financing ; and research activities. In addition, the company offers financial advisor-led brokerage, investment advisory, custody, cash management, and administrative services ;
self-directed brokerage services ; financial and wealth planning services ; stock plan administration ; securities-based lending, residential real estate loans, and other lending products ; banking ; and retirement plan services. Further, it provides equity, fixed income, alternatives and solutions, and liquidity and overlay services to benefit/defined contribution plans, foundations, endowments, government entities, sovereign wealth funds, insurance companies, third-party fund sponsors, corporations, and individuals. Morgan Stanley was founded in 1924 and is headquartered in New York, New York.
Sector
Financials
Industry
Capital Markets
Primary listing
Nyse
United States
CEO
Mr. Edward N. Pick
Founded
1924
Employees
83 000
Revenue / employee
851 807 USD
Next earnings
January 14, 2027
Institutional holders
- GEODE CAPITAL MANAGEMENT, LLC1.78%
- FMR LLC1.45%
- Bank of New York Mellon Corp0.56%
- Rest of the register96.21%
3 13F filings as of September 30, 2026: US managers above $100M, filed up to 45 days after quarter end. No insiders, no retail. A share on loan is declared by its lender and by whoever bought it from the short seller, so the total can exceed 100%.
Research uses the underlying stock’s market history. The purchase quote is calculated separately when you review your order.
52-week high
232.25 USD
52-week low
152.80 USD
1-year performance
13.63%
Rising
Year-to-date performance
6.63%
Rising
Drawdown
-18.08%
Marked drawdown
Position in the 52-week range
47% of range
Against the world ETF
Over 26 years, from December 2000 to October 2026, the share did not clearly beat the world ETF once risk is accounted for. It earned less, while shaking 2.3 times harder.
$10,000 placed at the end of December 2000 are worth today
| Morgan Stanley | $47,229 |
| World ETF | $65,117 |
| S&P 500 | $91,204 |
| Risk-free placement | $15,894 |
The risk
- Shaking:the share moves 2.3 times as much as the world ETF.
- Worst fall:-80 % between May 2007 and May 2012. $10,000 placed at the top fell to $2,005. The world ETF, at worst: -53 %. Back to its high in 102 months.
Morgan Stanley earned less than the world ETF since 2000
Value of $10,000 placed at the end of December 2000, dividends reinvested, in dollars
- Morgan Stanley: $47,229
- World ETF: $65,117
- S&P 500: $91,204
- Risk-free placement: $15,894
Based on past performance. This is not a recommendation.
Range: 185.00 USD - 262.00 USD (2 methods agree)
The price implies growth of -7.60% per year; the company grows at 9.56%.
Net margin 25.5%, ROE 18.0%.
Net margin
25.52%
Fair
Sector 23.07%|S&P 13.40%
Gross margin
—
Return on equity (ROE)
18.02%
Exceptional
Sector 11.80%|S&P 17.06%
Return on invested capital (ROIC)
4.32%
Free cash flow margin (FCF)
29.17%
Profit-to-cash conversion (FCF conversion)
1.14x
Margin stability
2.9 pts
Steady
Revenue to net income
Growth
5.2/10Revenue up 6.5% over 1 year, 17.8% a year over 5, EPS 9.6% a year over 5.
Revenue (trailing 12 months)
80.2Md USD
Revenue growth (1y)
6.48%
Solid
Revenue growth (3y)
81.42%
Strong
EPS growth (1y)
8.40%
Moderate
EPS CAGR (5y)
9.56%
Strong
EPS revisions (3 months)
-0.53%
Revised down
Valuation
5.5/10P/E 15.1x, forward P/E 14.7x, PEG 1.58. The multiple sits in the 72th percentile of its own 5-year history.
P/E (TTM)
15.1x
Fair
Sector 14.0x|S&P 23.6x
Forward P/E
14.7x
Fair
EV / EBITDA
—
Sector 9.7x|S&P 15.5x
PEG
1.58
Expensive
Sector 0.58|S&P 0.91
Fair value (reverse DCF)
218.70 USD
Undervalued
P/E vs its own 5-year history
among the 28% highest valuations
Pricier than usual
Market cap
297Md USD
Not scored for a bank or an insurer: its solidity is measured by regulatory capital ratios, which we do not collect.
Net debt / EBITDA
—
Gearing (net debt / equity)
442.49%
Cash
139Md USD
Cash / market cap
46.63%
Cash / total debt
26.18%
Net debt
524Md USD
Equity
118Md USD
Closed daily candles, 2 years
Last close on November 10, 2026: 187.56 USD
- MM20184.63
- MM50194.11
- MM200194.40
- RSI 1449.5
Top panel: closed candles, 20, 50 and 200-day moving averages, with volume in grey. Bottom panel: 14-day RSI with dashed 30 and 70 levels.
200-day average slope, 1 month
+0.07%
200-day average slope, 3 months
+4.16%
50-day average slope, 1 month
-6.19%
Price structure
Lower lows
Bullish RSI divergence
No
20-day volatility
2.42 % per day
Volatility change
+45.07%
Forecasts by fiscal year
| Fiscal year | EPS | Normalised EPS | Revenue | EBITDA | Net income |
|---|---|---|---|---|---|
| 2026 | 12.91 (22) | 12.90 (20) | 82 487 (17) | — | 20 164 (17) |
| 2027 | 13.69 (22) | 13.67 (20) | 86 641 (17) | — | 20 992 (17) |
Amounts in millions of USD, EPS in USD per share. In brackets, the number of analysts. Consensus as of November 8, 2026.
Same sub-industry: 183 companies behind the medians.
| # | Company | Code | Country | Overall / 10 | Fundamentals / 10 | Mkt cap | P/E | Net margin | Revenue growth | ROIC | Net debt / EBITDA | FCF yield | 1-year perf. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SCHW | 7.5 | 7.4 | 160Md USD | 15.8x | 34.9 % | 16.0 % | 14.4 % | -2.8x | -7.4 % | -2.3 % | ||
| 2 | GS | 6.6 | 7.4 | 267Md USD | 13.3x | 31.3 % | 17.2 % | — | — | — | 16.1 % | ||
| 3 | IBKR | 6.4 | 5.2 | 140Md USD | 31.5x | 10.1 % | 13.2 % | — | — | — | 17.0 % | ||
| 4 | 600030 | 6.2 | 6.2 | 55.9Md USD | 10.1x | 41.6 % | -18.3 % | 7.2 % | 10.9x | 38.5 % | -13.7 % | ||
| 5 | MS | 6.2 | 6.2 | 297Md USD | 15.1x | 25.5 % | 6.5 % | — | — | — | 13.6 % | ||
| 6 | RJF | 6.1 | 6.3 | 32.1Md USD | 14.0x | 13.5 % | 13.5 % | — | — | — | 3.2 % | ||
| 7 | HOOD | 5.8 | 4.4 | 76.2Md USD | 39.0x | 38.5 % | 11.7 % | 18.4 % | 5.1x | -3.6 % | -36.9 % | ||
| 8 | 8604 | 5.6 | 6.1 | 27.1Md USD | 11.2x | 8.1 % | 13.9 % | — | — | — | 37.5 % | ||
| 9 | 601211 | 5.5 | 4.9 | 40.7Md USD | 8.9x | 38.7 % | 7.3 % | 4.3 % | 17.6x | 59.1 % | -19.3 % |
